956901-17-0

Usage

Uses

Used in Pharmaceutical Industry:
7-fluoroquinoline-6-carbonitrile is used as a building block for the synthesis of various pharmaceuticals. Its unique structure and functional groups contribute to the development of new drugs with improved therapeutic properties.
Used in Agrochemical Industry:
7-fluoroquinoline-6-carbonitrile is also utilized as a key intermediate in the synthesis of agrochemicals, playing a crucial role in the development of effective pesticides and other agricultural chemicals.
Used in Organic Chemistry:
7-fluoroquinoline-6-carbonitrile serves as a versatile intermediate in organic chemistry, enabling the synthesis of a wide range of organic compounds for various applications.
Used in Medicinal Chemistry and Drug Discovery:
7-fluoroquinoline-6-carbonitrile is employed as a valuable intermediate in medicinal chemistry and drug discovery. Its unique properties and functional groups make it an important scaffold for the development of new chemical entities with potential therapeutic and biological activities.

Upstream product

• 127827-52-5 6-bromo-7-fluoroquinoline 
• 656-65-5 3-fluoro-4-bromophenylamine 
• 367-24-8 4-bromo-2-fluoroaniline 
• 544-92-3 copper(I) cyanide 

Relevant academic research and scientific papers

NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN, ETC

The present invention provides compounds useful as c-Met protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of c-Met kinase mediated disease or disorders with them.

NOVEL 3,5-DISUBSTITUED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN KINASES

The present invention provides compounds useful as C-met protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of C-met kinase mediated diseases or disorders with them.

NOVEL 3,5-DISUBSTITUED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN KINASES

The present invention provides, inter alia, compounds of formula ΙΑ,ΙΙΑ and III as protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.

NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5- DISUBSTITUTED -3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF PROTEIN KINASES

The present invention provides, inter alia, compounds of formula I as protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.

TRIAZOLOPYRAZINE DERIVATIVES

The invention relates to compounds of the formula I or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.